Why does mycobacterial testing rely on both culture and molecular methods?

Mycobacteria grow slowly, so culture-based identification and susceptibility testing can take weeks. Molecular assays detect the organism and key resistance markers, such as rifampin resistance, directly from a specimen within hours, complementing culture (Boehme et al., 2010).

Mycobacterial Identification and Resistance

Mycobacterial identification and resistance testing are the laboratory methods used to detect Mycobacterium tuberculosis and other mycobacteria, identify them to species, and determine their susceptibility to antimycobacterial drugs. Because mycobacteria grow slowly, the field combines microscopy and culture with rapid molecular assays that can detect both the organism and key resistance markers.

Definition

Mycobacterial identification is the laboratory detection and species-level identification of mycobacteria from a clinical specimen; resistance testing is the determination, by phenotypic or molecular methods, of a mycobacterial isolate's susceptibility to antimycobacterial agents.

Scope

The entry covers acid-fast microscopy, mycobacterial culture, species identification, phenotypic and molecular drug-susceptibility testing, and the rapid molecular detection of resistance such as rifampin resistance in tuberculosis. It treats these as laboratory methods and does not provide treatment regimens or dosing.

Core questions

Are mycobacteria present in this specimen, and is the organism Mycobacterium tuberculosis or a non-tuberculous species?
Which methods - acid-fast microscopy, culture, molecular assays, or proteomic identification - detect and identify mycobacteria?
Is the isolate resistant to key antimycobacterial drugs, and how is that determined phenotypically or molecularly?
How do the slow growth of mycobacteria and the speed of molecular assays shape laboratory workflow?

Key concepts

Acid-fast (Ziehl-Neelsen, auramine) microscopy
Mycobacterial culture (solid and liquid media)
Mycobacterium tuberculosis complex versus non-tuberculous mycobacteria
Phenotypic drug-susceptibility testing
Molecular detection of resistance (e.g. rifampin resistance)
Nucleic-acid amplification for direct detection
Line probe and cartridge-based assays
Slow growth and turnaround time

Mechanisms

Detection of mycobacteria begins with acid-fast microscopy, which stains the lipid-rich cell wall, and with culture on solid or liquid media that, because mycobacteria grow slowly, may take weeks. Species identification distinguishes the Mycobacterium tuberculosis complex from non-tuberculous mycobacteria using molecular probes, sequencing, or proteomic methods such as mass spectrometry (Clark et al., 2013). Drug-susceptibility testing is done phenotypically by growth in the presence of drugs or, increasingly, by molecular detection of resistance-associated mutations. Automated cartridge-based nucleic-acid amplification can detect M. tuberculosis and rifampin resistance directly from a specimen within hours rather than the weeks needed for culture-based testing (Boehme et al., 2010), and real-time PCR more broadly supports direct molecular detection in the laboratory (Espy et al., 2006). Comprehensive reviews place these laboratory methods within the wider diagnostic and surveillance landscape of tuberculosis (Pai et al., 2016).

Clinical relevance

Identifying mycobacteria and detecting drug resistance produce information central to clinical reasoning about tuberculosis and non-tuberculous mycobacterial disease and to public-health control. This entry describes how those laboratory results are generated and what limits them; it is reference material and does not prescribe antimycobacterial regimens or dosing for an individual.

Epidemiology

Mycobacterial laboratory testing is integral to tuberculosis control: rapid molecular detection of the organism and of resistance shortens the path to recognising drug-resistant tuberculosis and informs surveillance (Boehme et al., 2010). Reviews of tuberculosis emphasise the role of diagnostics in the global epidemiology and management of the disease (Pai et al., 2016).

History

Mycobacterial diagnosis rested for over a century on acid-fast microscopy and slow culture, with phenotypic drug-susceptibility testing added later. The introduction of nucleic-acid amplification and, notably, automated cartridge-based assays able to report M. tuberculosis and rifampin resistance directly from sputum within hours marked a major change in laboratory practice (Boehme et al., 2010), set within the broader expansion of molecular microbiology (Espy et al., 2006).

Seminal works

boehme-2010
pai-2016
espy-2006

Frequently asked questions

Why does mycobacterial testing rely on both culture and molecular methods?: Mycobacteria grow slowly, so culture-based identification and susceptibility testing can take weeks. Molecular assays detect the organism and key resistance markers, such as rifampin resistance, directly from a specimen within hours, complementing culture (Boehme et al., 2010).
What distinguishes Mycobacterium tuberculosis from non-tuberculous mycobacteria in the laboratory?: Both are acid-fast, so microscopy alone cannot separate them; species-level identification uses molecular probes, sequencing, or proteomic methods to distinguish the M. tuberculosis complex from non-tuberculous mycobacteria (Clark et al., 2013).